Cite

    Juan J Russo et al.. “Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y12 receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgery.” European heart journal, vol. 8, no. 6, 2019, pp. 543–553. http://access.bl.uk/ark:/81055/vdc_100087820601.0x000006